This paper is in the following e-collection/theme issue:

mHealth for Data Collection and Research (917) Digital Biomarkers and Digital Phenotyping (178) Fitness Trackers and Smart Pedometers/Accelerometers (543) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1317) Wearable Devices and Sensors (825)

Published on in Vol 7, No 12 (2019): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13433, first published .
Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study

Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study

Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study

Authors of this article:

Luis Garcia-Gancedo1 Author Orcid Image ;   Madeline L Kelly2 Author Orcid Image ;   Arseniy Lavrov3 Author Orcid Image ;   Jim Parr4 Author Orcid Image ;   Rob Hart4 Author Orcid Image ;   Rachael Marsden5 Author Orcid Image ;   Martin R Turner5 Author Orcid Image ;   Kevin Talbot5 Author Orcid Image ;   Theresa Chiwera6 Author Orcid Image ;   Christopher E Shaw6 Author Orcid Image ;   Ammar Al-Chalabi6 Author Orcid Image
Article Authors Cited by (30) Tweetations (35) Metrics

Luis Garcia-Gancedo   1 , PhD ;   Madeline L Kelly   2 , PhD ;   Arseniy Lavrov   3 , MD ;   Jim Parr   4 , PhD ;   Rob Hart   4 , MEng ;   Rachael Marsden   5 , BSc ;   Martin R Turner   5 , PhD ;   Kevin Talbot   5 , PhD ;   Theresa Chiwera   6 , BSc ;   Christopher E Shaw   6 , FRACP ;   Ammar Al-Chalabi   6 , PhD

1 Advanced Biostatistics & Data Analytics Centre of Excellence, R&D Projects Clinical Platforms & Sciences, GlaxoSmithKline, Stevenage, United Kingdom

2 Translational Medicine, Future Pipeline Discovery, GlaxoSmithKline, Stevenage, United Kingdom

3 Clinical Development, AveXis, Bannockburn, IL, United States

4 McLaren Technology Centre, McLaren Applied Technologies, Woking, United Kingdom

5 Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom

6 Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King’s College London, London, United Kingdom

Corresponding Author:

  • Luis Garcia-Gancedo, PhD
  • Advanced Biostatistics & Data Analytics Centre of Excellence
  • R&D Projects Clinical Platforms & Sciences
  • GlaxoSmithKline
  • Gunnels Wood Road
  • Stevenage, SG1 2NY
  • United Kingdom
  • Phone: 44 1438 762129
  • Email: luis.x.garcia-gancedo@gsk.com